The Evolving Role of High‐Sensitivity C‐Reactive Protein for Mortality Prediction Across the Spectrum of Cardiovascular–Kidney–Metabolic Syndrome

Documenti analoghi

• Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation
  di: Xue Tian, et al.
  Pubblicazione: (2026)
• Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
  di: Ruobing Tian, et al.
  Pubblicazione: (2025)
• Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular‐Kidney‐Metabolic Syndrome
  di: Evan Zeitler, et al.
  Pubblicazione: (2026)
• Prevalence of Albuminuria Across Cardiovascular‐Kidney‐Metabolic Phenotypes in the United States
  di: Sophie E. Claudel, et al.
  Pubblicazione: (2026)
• Proteomic Profiling Captures Residual Cardiovascular Risk Beyond the PREVENT Model in Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 2–3
  di: Xuefei Han, et al.
  Pubblicazione: (2026)